Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
UC panel showcases iSPY trial, immunotherapy advances and a patient survivor story
Summary
A UC INSPIRES panel highlighted the iSPY adaptive clinical-trial consortium, a large shared biorepository, and UCLA preclinical CAR NKT work that panelists say could dramatically reduce manufacturing cost if clinical translation succeeds; a UC San Diego employee recounted how trials saved her life.
A panel at the University of California Board of Regents’ Jan. 7 meeting profiled how UC research is translating into clinical advances, featuring a patient survivor whose participation in trials and proton therapy contributed to durable remission, and researchers who described collaborative platforms that accelerate drug development.
Michelle Brubaker, a UC San Diego Health employee and patient, recounted an aggressive breast cancer diagnosis and treatment that included participation in two clinical trials; she said enrollment in the iSPY trial produced rapid tumor shrinkage and remains part of her ongoing follow‑up. "Research saved my life," Brubaker said, describing…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
